Induction of fetal hemoglobin by recombinant human erythropoietin in patients with end-stage renal disease.
Salvati
F
F
D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000627:therapeutic use*; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
D011994:Recombinant Proteins; D004921:Erythropoietin; D005319:Fetal Hemoglobin